Alentis Appoints Alberto Toso Chief Scientific Officer : com

BASEL, Switzerland, April 29, 2024--Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective immediately. Alberto joined Alentis in 2021 as Head of Oncology.

Related Keywords

France , Bellinzona , Ticino , Switzerland , Zurich , Züsz , French , Thomas Baumert , Sariette Witte , Alberto Toso , Roberto Iacone , Opatrick Wilson , French National Institute Of Health , Research Inserm , Nature Communications , University Of Strasbourg , Department Head , Institute Of Oncology Research In Bellinzona , Alentis Therapeutics , Chief Scientific Officer , Chief Executive Officer , Oncology Research , French National Institute , Medical Research ,